Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer ...

Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’ ...

The measure that proponents say could save many lives has been rejected by the Government ...

Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...

Only men with a specific gene variant and a family history of certain cancers should be screened, experts have said.

Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

The UK's National Screening Committee has concluded its review of prostate cancer screening in the UK, saying that the harms of a large-scale, national programme would outweigh the benefits. The ...

Ten common reasons your prostate test results might be falsely elevated ...